drugset / Trial / NCT04995159
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to verify the safety and efficacy of Lepu® NeoVas™ Bioabsorbable Coronary Artery Rapamycin-eluting Stent System combined with different antiplatelet therapies in the treatment of coronary heart disease.
Timeline
- Start
- 2021-09
- Primary completion
- 2026-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | — |
| Subject | Clopidogrel | Small molecule | — | — |
| Background | Ticagrelor | Small molecule | — | — |